What Dotixa is and what it is used for
Dotixa contains the active substance Dasatinib.
Dotixa is used to treat Philadelphia chromosome positive (Ph+) Chronic Myeloid Leukemia (CML) in adults, adolescents and children at least 1 year of age who are not benefiting from prior therapies.
Dotixa is also used to treat Philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia (ALL) in adults, adolescents and children at least 1 year of age. In people with ALL, white cells called lymphocytes multiply too quickly and live too long. Dotixa inhibits the growth of these leukemic cells.
If you have any questions about how Dotixa works or why this medicine has been
Prescribed for you, ask your doctor.
What you need to know before you take Dotixa
Do not take Dotixa:
If you could be allergic, ask your doctor for advice.
Warnings and precautions
Talk to your doctor or pharmacist before using Dotixa
and Dotixa”)
Dotixa: this may be a sign of fluid retention in the lungs or chest (which can be
more common in patients aged 65 years and older), or due to changes in the blood
vessels supplying the lungs
Dotixa could cause hepatitis B to become active again, which can be fatal in some cases. Patients will be carefully checked by their doctor for signs of this infection before treatment is started.
Dotixa contact your doctor. This may be a sign of damage to blood vessels known as thrombotic microangiopathy (TMA).
Your doctor will regularly monitor your condition to check whether Dotixa is having the
desired effect. You will also have blood tests regularly while you are taking Dotixa
Children and adolescents
Do not give this medicine to children younger than one year of age. There is limited
experience with the use of Dotixa in this age group. Bone growth and development will be
closely monitored in children taking Dotixa.
Other medicines and Dotixa
Tell your doctor if you are taking, have recently taken or might take any other medicines.
Dotixa is mainly handled by the liver. Certain medicines may interfere with the effect of Dotixa when taken together.
These medicines are not to be used with Dotixa:
depression and other conditions (also known as Hypericum perforatum)
Do not take medicines that neutralise stomach acids (antacids such as aluminium hydroxide
or magnesium hydroxide) in the 2 hours before or 2 hours after taking Dotixa.
Tell your doctor if you are taking medicines to thin the blood or prevent clots.
Dotixa with food and drink
Pregnancy and breast-feeding
If you are pregnant or think you may be pregnant, tell your doctor immediately. Dotixa
is not to be used during pregnancy unless clearly necessary. Your doctor will discuss with
you the potential risk of taking Dotixa during pregnancy.
Both men and women taking Dotixa will be advised to use effective contraception during
treatment.
If you are breast-feeding, tell your doctor. You should stop breast-feeding while you are
taking Dotixa.
Driving and using machines
Take special care when driving or using machines in case you experience side effects such as
dizziness and blurred vision.
Dotixa contains lactose
If you have been told by your doctor that you have an intolerance to some sugars, contact
your doctor before taking this medicinal product
Dotixa contains sodium
This medicine contains less than 1 mmol sodium (23 mg) per tablets, that is to say essentially
‘sodium-free’
How to take Dotixa
Take your tablets at the same time every day.
Swallow the tablets whole. Do not crush, cut or chew them. Do not take dispersed tablets.
You cannot be sure you will receive the correct dose if you crush, cut, chew or disperse the
tablets.
Special handling instructions for Dotixa
It is unlikely that the Dotixa tablets will get broken. But if they do, persons other than the patient should use gloves when handling Dotixa .
How long to take Dotixa
Take Dotixa daily until your doctor tells you to stop. Make sure you take Dotixa for
as long as it is prescribed.
If you take more Dotixa than you should
If you have accidentally taken too many tablets, talk to your doctor immediately. You may
require medical attention.
If you forget to take Dotixa
Do not take a double dose to make up for a forgotten tablet. Take the next scheduled dose at
the regular time.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Dotixa will only be prescribed to you by a doctor with experience in treating leukaemia.
Always take this medicine exactly as your doctor has told you. Check with your doctor or
pharmacist if you are not sure. Dotixa is prescribed for adults and children at least 1 year of age.
Dotixa is administered orally once daily in the form of either Dotixa tablets. Dotixa tablets are not recommended for patients weighing less than 10 kg.
Your doctor will decide the right formulation and dose based on your weight, any side effects and response to treatment. The starting dose of Dotixa for children is calculated by body weight as shown below:
Body Weight (kg)ª | Daily Dose (mg) |
10 to less than 20 kg | 40 mg |
20 to less than 30 kg | 60 mg |
30 to less than 45 kg | 70 mg |
at least 45 kg | 100 mg |
ª The tablet is not recommended for patients weighing less than 10 kg;
There is no dose recommendation for Dotixa with children under 1 year of age.
Depending on how you respond to the treatment, your doctor may suggest a higher or lower
dose, or even stopping treatment briefly. For higher or lower doses, you may need to take
combinations of the different tablet strengths.
Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The following can all be signs of serious side effects:
mucous membranes
Contact your doctor immediately if you notice any of the above.
Very common side effects (may affect more than 1 in 10 people)
headache, feeling tired or weak, bleeding
tummy (abdominal) pain
Common side effects (may affect up to 1 in 10 people)
upper respiratory tract infection, serious infection of the blood or tissues (including
uncommon cases with fatal outcomes)
heart muscle, high blood pressure, increased blood pressure in the lungs, cough
tummy (abdomen), inflammation of the colon, constipation, heartburn, mouth
ulceration, weight increase, weight decrease, gastritis
skin, persistent noise in ears, hair loss, excessive perspiration, visual disorder
(including blurred vision and disturbed vision), dry eye, bruise, depression, insomnia,
flushing, dizziness, contusion (bruising), anorexia, somnolence, generalised oedema
chills, stiffness in muscles and joints, muscle spasm
neutropaenia, gastrointestinal bleeding, high uric acid levels in the blood
Uncommon side effects (may affect up to 1 in 100 people)
(fibrous sack) surrounding the heart, irregular heartbeat, chest pain due to lack of
blood supply to the heart (angina), low blood pressure, narrowing of airway that may
cause breathing difficulties, asthma, increased blood pressure in the arteries (blood
vessels) of the lungs
food pipe, swollen tummy (abdomen), tear in the skin of the anal canal, difficulty in
swallowing, inflammation of the gallbladder, blockage of bile ducts, gastro-oesophageal
reflux (a condition where acid and other stomach contents come back up
into the throat)
(erythema nodosum), anxiety, confusion, mood swings, lower sexual drive, fainting,
tremor, inflammation of the eye which causes redness or pain, a skin disease
characterized by tender, red, well-defined blotches with the sudden onset of fever and
raised white blood cell count (neutrophilic dermatosis), loss of hearing, sensitivity to
light, visual impairment, increased eye tearing, disturbance in skin colour,
inflammation of fatty tissue under the skin, skin ulcer, blistering of the skin, nail
disorder, hair disorder, hand-foot disorder, renal failure, urinary frequency, breast
enlargement in men, menstrual disorder, general weakness and discomfort, low
thyroid function, losing balance while walking, osteonecrosis (a disease of reduced
blood flow to the bones, which can cause bone loss and bone death), arthritis, skin
swelling anywhere in the body
inflammation of the tendon
caused by the waste products of the dying tumour (tumour lysis syndrome), low
levels of albumin in the blood, low levels of lymphocytes (a type of white blood cell)
in the blood, high level of cholesterol in the blood, swollen lymph nodes, bleeding in
the brain, irregularity of the electrical activity of the heart, enlarged heart,
inflammation of the liver, protein in the urine, raised creatine phosphokinase (an
enzyme mainly found in the heart, brain and skeletal muscles), raised troponin (an
enzyme mainly found in the heart and skeletal muscles), raised gamma-glutamyltransferase (an enzyme mainly found in the liver)
Rare side effects (may affect up to 1 in 1,000 people)
heart muscle, collection of conditions resulting from blockage of blood supply to the
heart muscle (acute coronary syndrome), cardiac arrest (stopping of blood flow from
the heart), coronary (heart) artery disease, inflammation of the tissue covering the
heart and lungs, blood clots, blood clots in the lungs
bowel obstruction, anal fistula (an abnormal opening from the anus to the skin around
the anus), impairment of kidney function, diabetes
a complete or partial loss of vision, blue-purple mottling of the skin, abnormally high
thyroid function, inflammation of the thyroid gland, ataxia (a condition associated
with lack of muscular coordination), difficulty walking, miscarriage, inflammation of
the skin blood vessels, skin fibrosis
flow, facial nerve paralysis, dementia
form joints (epiphyses); slower or delayed growth
Other side effects that have been reported with frequency not known (cannot be
estimated from the available data)
the past (a liver infection)
test results such as protein in the urine and low protein level in the blood
decreased red blood cell count, decreased platelets, and formation of blood clots
Your doctor will check for some of these effects during your treatment.
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side
effects not listed in this leaflet.
How to store Dotixa
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the blister or carton after EXP.
The expiry date refers to the last day of that month.
Store below 30°C. Protect from light and moisture.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
Further information
What Dotixa contains
The active substance of this medicine is Dasatinib.
The other ingredients are:
What Dotixa looks like and contents of the pack
Dotixa 100 mg film-coated tablets are white to off-white colored, Oval shaped, biconvex
Dotixa 70 mg film-coated tablets are white to off-white colored, round shaped, biconvex
Each pack contains 30 film-coated tablets (3 blisters of 10 tablets).
Manufactured by:
Actero Middle East Pharmaceutical Company, Karaj, Iran